(EBC) patients receiving Kisqali in 1-year post-treatment analysis1Tolerability remained consistent, with fewer treatment discontinuations due to adverse events among pre-menopausal patients1Rising br ...

Australia is undergoing rapid population growth, but the way we’re planning for it (or rather, not planning for it) is setting us up for failure.